Skip to content

ARS Pharmaceuticals, Inc.: filings

Every ARS Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 22 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 2026411170001193125-26-349140
10-Q2026-05-15fiscal Q1 202641850001193125-26-225142
10-K2026-03-09fiscal FY 202547940001193125-26-097478
10-Q2025-11-10fiscal Q3 2025431260001193125-25-273111
10-Q2025-08-13fiscal Q2 2025421200000950170-25-107618
10-Q2025-05-14fiscal Q1 202542860000950170-25-070900
10-K2025-03-20fiscal FY 202448950000950170-25-042320
10-Q2024-11-13fiscal Q3 2024401120000950170-24-125924
10-Q2024-08-06fiscal Q2 2024361030000950170-24-091776
10-Q2024-05-09fiscal Q1 202437770000950170-24-056967
10-K2024-03-21fiscal FY 202340810000950170-24-034689
10-Q2023-11-09fiscal Q3 2023381070000950170-23-061996
10-Q2023-08-10fiscal Q2 2023381040000950170-23-041310
10-Q2023-05-15fiscal Q1 202337770000950170-23-021997
10-K2023-03-23fiscal FY 202239790000950170-23-009491
10-Q2022-11-02fiscal Q3 2022331000000950170-22-021234
10-Q2022-08-11fiscal Q2 202230810000950170-22-016840
10-Q2022-05-12fiscal Q1 202229610000950170-22-009694
10-K2022-03-31fiscal FY 202134690000950170-22-005202
10-Q2021-11-10fiscal Q3 202130810000950170-21-004106
10-Q2021-08-12fiscal Q2 202128750000950170-21-001379
10-Q2021-05-13fiscal Q1 202128590001193125-21-160519

Inspect the source

Entity
ARS Pharmaceuticals, Inc. / CIK 0001671858
Captured
2026-09-21T17:22:41.931Z
SEC response SHA-256
2c5a7142d269b28831cca7ac1261f0995af95a67f581ad2648504d2117d943c8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001671858.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))